Tarek Rabah
Vice President, Renal-Cardio
Responsibilities
Tarek Rabah currently leads the US Renal Therapy area at AstraZeneca, where he oversees the successful commercialization and sales efforts of kidney disease products in the US.
Prior experience
From 2008 to 2016, he served as President of a multi-country region for AstraZeneca, directly responsible for the P&L of over $1.1B and a team of more than 2,600 professionals in the Middle East & Africa. Tarek started his career at Novartis in 1998 and throughout his professional journey Tarek has successfully launched brands and led divisions in the US, Brazil, Europe, Japan, the Middle East and Africa. In addition to his native Arabic, Tarek is fluent in English, French, Portuguese and Spanish.
Education
- Bachelor of Science, Biology and Business Administration, American University of Beirut
- Master of Business Administration, McGill University
- Additional education at Harvard University
Global leadership team
Our leadership, which includes our Board of Directors and Senior Executive Team represents the interests of all our stakeholders in ensuring that we deliver for patients by putting science at the heart of everything we do.
What science can do
Stories from our people and our partners reveal the passion, energy and knowledge that enable us to put science at the heart of everything we do.
Our company
We are a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
Join AstraZeneca
and help us deliver life-changing medicines
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.